Skip to content
Open access

Saturated mutagenesis screen of M-MLV reverse transcriptase identifies variants enhancing prime editing efficiency

Jul 2026 · bioRxiv · 0 citations · 14 references
Biology

TL;DR

A compact prime editor is developed by deleting the RNase H domain of the MMLV reverse transcriptase and a saturated mutagenesis screen targeting two DNA interacting regions within the PE2ΔR-RT Fingers domain is conducted to identify novel mutations that enhance prime editor performance.

Abstract

Prime editing enables the precise modification of genomes, thereby holding great potential for the treatment of genetic diseases. Despite substantial advancements in prime editing technology and the initiation of the first clinical trial for treating chronic granulomatous disease, further enhancement of editing efficiency across edit types is still urgently needed. Here, we developed a compact prime editor, PE2ΔR, by deleting the RNase H domain of the MMLV reverse transcriptase (MMLV-RT). We then conducted a saturated mutagenesis screen targeting two DNA interacting regions within the PE2ΔR-RT Fingers domain. By integrating three highly effective mutations (I61R, V101R, S67W) into PEmax lacking RNase H domain (termed PEmaxΔRM3), we achieved up to a 90% increase in editing efficiency across editing types compared to PEmax. Structural modelling using AlphaFold 3 suggests that these mutations enhance primer–template stabilization and guide the RNA/DNA hybrid into a catalytically favourable trajectory, providing a mechanistic explanation for the enhanced activity. Taken together, our study demonstrates proof-of-concept for the application of unbiased mutagenesis screen to identify novel mutations that enhance prime editor performance. Furthermore, we discovered that RT variants (I61R, V101R, S67W) synergize with PEmax and epegRNA to improve prime editing efficiency across edit types, with the strongest improvement observed in introducing small deletions.

Read PDF

Similar papers

Review Open access Jul 2026

Base editing for precision therapeutics.

Key remaining challenges include bystander editing within the activity window, residual off-target DNA and RNA editing, delivery constraints, delivery constraints, immunogenicity, and the need for durable long-term safety evidence across relevant cell types and disease contexts.

Moksada Regmi, K. Ma, C. Bi et al. · 0 citations
Open access Aug 2026

Compact 9dBEs Enable Efficient and Precise Genome Editing in Mammalian Cells and In Vivo

An efficient Cas9d system (Cas9dUltra) is developed through gRNA and protein engineering, and its base editors (9dBEs) further developed through gRNA and protein engineering, enabling efficient and precise genome editing in human cells.

Qingquan Xiao, Zhijin Tian, Luqi Weng et al. · 0 citations
Review Aug 2026

Recent advances in base editing technology and its applications in disease therapy.

This review focuses on the action mode of different base editors, highlights their interplays with the TLS, summarizes their potential therapeutic applications and discusses perspective strategies to improve precision and expand targeting scope.

Rui Tao, Min Li, Tongyun Luo et al. · 0 citations
Jul 2026

Development and Characterization of RNA Aptamer-Mediated Modular Base Editors Containing Staphylococcus aureus Cas9 Derivatives and Novel Deaminase Orthologs

The effectiveness of the SaCas9 modular base editors, the robustness of the platform’s modularity, and its feasibility for convenient screening of target-specific base editors are demonstrated.

J. Collantes, Kellen Xu, M. Ruiz-Urigüen et al. · 0 citations
Open access Jul 2026

Rational and computation-assisted engineering of a compact and efficient StaCas9 genome editor

Natural variation in PAM recognition among SaCas9 orthologs is analyzed and StaCas9 is identified as a compact and efficient nuclease recognizing an NNG PAM, establishing StaCas9 as a high-performance genome-editing tool for therapeutic applications.

Miaomiao Li, Wenni You, Yuwen Tian et al. · 1 citation
Open access Jul 2026

High-diversity base mutagenesis via simultaneous adenine, cytosine and guanine editing

Base editors hold great promise in endogenous mutagenesis for genetic screening. However, the development of base editors that induce saturated multi-base conversions with diverse mutation spectrum is challenging. Here, we develop triple base editors (smACGs) that simultaneously mutagenize adenine, cytosine, and guanine within the same allele. Through screening and embedding engineered deaminase and alkyladenine DNA glycosylase variants in Cas9 structure, smACGmax is generated to catalyze robust triple-base conversion efficiencies of up to 41% across varied sequence contexts while maintaining low RNA off-target effects compared to previous dual-base editors. We apply smACGmax to enable high coverage (94%) of targeted HBEGF mutagenesis that identified diphtheria toxin-resistant mutations and to dissect SF3B1 variants with alternative splicing specificity via complex single, double, and triple base conversion screening. smACGmax expands base conversion capability from single and double substrates to trinucleotide level, which facilitates the generation of high-diversity and complex genetic variants, providing a useful platform for mutagenesis-based application. Broad-spectrum base mutagenesis at the same endogenous loci with base editors remains a challenge. Here, the authors developed smACGmax to catalyze efficient multi-base conversions across adenine, cytosine and guanine, and enable high-diversity functional screening in HBEGF and SF3B1 variants.

Meng-Jia Hong, Changming Luan, Meng Yuan et al. · 0 citations